丁苯酞对急性分水岭脑梗死患者血浆溶血磷脂酸水平的影响及近期疗效分析(4)
[11]王健松,郭来敬,胡大一.脑分水岭梗死的发病机制与诊疗研究进展[J].临床荟萃,2010,25(23):2111-2114.
[12]Sorgun MH,Rzayev S,Yilmaz V,et al.Etiologic Subtypes of watershed infarcts[J].J Stroke Cerebrovasc Dis,2015,24(11):2478-2483.
[13]Choi JW,Chun J.Lysophospholipids and their receptors in the central nervous system[J].Biochim Biophys Acta,2013, 1831(1):20-32.
[14]Weber C,Noels H.Atherosclerosis:current pathogenesis and therapeutic options[J].Nat Med,2011,17(11):1410-1422.
[15]Lu XL,Luo D,Yao XL,et al.dl-3n-Butylphthalide promotes angio genesis via the extracellular signal-regulated kinase 1/2 and phosphati dylinositol 3-kinase/Akt-endothelial nitric oxide synthase signaling pathways[J].J Cardiovasc Pharmacol,2012,59(4):352-362.
[16]Li J,Li Y,Ogle M,et al.DL-3-n-Butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway[J].Brain Res,2010,1359:216-226.
[17]吳晓清.丁苯酞软胶囊治疗急性分水岭脑梗死20例[J].中国药业,2013,22(13):99-100.
[18]吕丰收,韩卓娅.丁基苯酞联合阿司匹林治疗治疗脑分水岭梗死疗效分析[J].医药前沿,2012,2(10):205-206.
(收稿日期:2018-01-10 本文编辑:闫 佩), http://www.100md.com(常保强 马令秋)
[12]Sorgun MH,Rzayev S,Yilmaz V,et al.Etiologic Subtypes of watershed infarcts[J].J Stroke Cerebrovasc Dis,2015,24(11):2478-2483.
[13]Choi JW,Chun J.Lysophospholipids and their receptors in the central nervous system[J].Biochim Biophys Acta,2013, 1831(1):20-32.
[14]Weber C,Noels H.Atherosclerosis:current pathogenesis and therapeutic options[J].Nat Med,2011,17(11):1410-1422.
[15]Lu XL,Luo D,Yao XL,et al.dl-3n-Butylphthalide promotes angio genesis via the extracellular signal-regulated kinase 1/2 and phosphati dylinositol 3-kinase/Akt-endothelial nitric oxide synthase signaling pathways[J].J Cardiovasc Pharmacol,2012,59(4):352-362.
[16]Li J,Li Y,Ogle M,et al.DL-3-n-Butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway[J].Brain Res,2010,1359:216-226.
[17]吳晓清.丁苯酞软胶囊治疗急性分水岭脑梗死20例[J].中国药业,2013,22(13):99-100.
[18]吕丰收,韩卓娅.丁基苯酞联合阿司匹林治疗治疗脑分水岭梗死疗效分析[J].医药前沿,2012,2(10):205-206.
(收稿日期:2018-01-10 本文编辑:闫 佩), http://www.100md.com(常保强 马令秋)